Skip to main content
Skip to main content
Edgewise Therapeutics, Inc.
  • Investors & News
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
    • Posters & Publications
  • Disease Areas
  • Muscular Dystrophy
  • Hypertrophic Cardiomyopathy

Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

Explore Muscle
  • Science & Pipeline
  • Pipeline
  • Sevasemten
  • EDG-7500
  • Clinical Trials
  • Posters & Presentations

All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs.

Explore our Science
  • Patients & Families
  • Support for Becker
  • Support for Duchenne
  • Support for HCM
  • Patient Stories

We honor the experience of individuals and families living with and facing the challenges of serious muscle disease.

Read their stories
  • Company
  • Leadership Team
  • Careers
  • Contact

Our vision is to improve the lives of patients and families suffering from serious muscle diseases by building the world’s leading muscle-focused company.

Learn More
  • Corporate Profile
  • News
  • Events & Presentations
  • Analyst Coverage
  • Stock Info
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • Financials
    • Quarterly Results
    • SEC Filings
  • Governance
    • Governance Documents
    • Committee Composition
  • Resources
    • Investor FAQs
    • Investor Email Alerts
    • Investor Contacts
  • Investors & News
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
    • Posters & Publications

Investor FAQs

    Quick Links

    • SEC Filings
    • Leadership Team
    • Posters & Presentations

    IR Contact

    ir@edgewisetx.com

    Investor Email Alerts

    To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

    Edgewise Therapeutics, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

    By providing your email address below, you are providing consent to Edgewise Therapeutics, Inc. to send you the requested Investor Email Alert updates.

    * Required

    *
    Investor Alert Options
    *




    Unsubscribe

    Email Alert Sign Up Confirmation

    Edgewise Theraupetics, Inc. Logo

    Contact Us

    1715 38th St,
    Boulder, CO 80301

    720.262.7002

    info@edgewisetx.com

    www.edgewisetx.com

    Quick Links

    • Company
    • Disease Areas
    • Science & Pipeline
    Powered By Q4 Inc. 5.153.0.3 (opens in new window)
    Follow us

    edgewise facebook edgewise x edgewise linkedin edgewise instagram edgewise youtube

    Contact Us Privacy Policy Terms of Use Cookie Preferences

    © 2025 Copyright. Edgewise Therapeutics. All Rights Reserved.